The LPS + PM group showed persistent inflammation characterized by BALF leukocytosis, increased IL-1β and IL-6 levels in the lung parenchyma, decreased alveolar air space volume, septal thickening and decreased septa surface density. The gene discussed is IL1B; the disease is Increased total leukocyte count.